Analysts at Bank of America began coverage on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a report released on Monday, The Fly reports. The brokerage set a “buy” rating on the stock. Reneo Pharmaceuticals Price Performance RPHM opened at $6.41 on Monday. The business has a fifty day simple moving average of $8.15 […]
Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) and Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends. Earnings and Valuation This table compares Reneo Pharmaceuticals and […]
IRVINE, Calif., June 30, 2023 Reneo Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic,.